415 related articles for article (PubMed ID: 31271898)
21. Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing.
Peacey E; Rodriguez L; Liu Y; Wolfe MS
Nucleic Acids Res; 2012 Oct; 40(19):9836-49. PubMed ID: 22844088
[TBL] [Abstract][Full Text] [Related]
22. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.
Wilton SD; Fletcher S
Curr Gene Ther; 2011 Aug; 11(4):259-75. PubMed ID: 21453280
[TBL] [Abstract][Full Text] [Related]
23. Alternative splicing in lung cancer.
Coomer AO; Black F; Greystoke A; Munkley J; Elliott DJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194388. PubMed ID: 31152916
[TBL] [Abstract][Full Text] [Related]
24. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
[TBL] [Abstract][Full Text] [Related]
25. Circular exonic RNAs: When RNA structure meets topology.
Pervouchine DD
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194384. PubMed ID: 31102674
[TBL] [Abstract][Full Text] [Related]
26. Making antisense of splicing.
Garcia-Blanco MA
Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
[TBL] [Abstract][Full Text] [Related]
27. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression.
Mercatante DR; Kole R
Biochim Biophys Acta; 2002 Jul; 1587(2-3):126-32. PubMed ID: 12084454
[TBL] [Abstract][Full Text] [Related]
28. Regulation of mammalian pre-mRNA splicing.
Hui J
Sci China C Life Sci; 2009 Mar; 52(3):253-60. PubMed ID: 19294350
[TBL] [Abstract][Full Text] [Related]
29. [Pre-mRNA splicing: when the spliceosome loses ground].
Dujardin G; Daguenet É; Bernard DG; Flodrops M; Durand S; Chauveau A; El Khoury F; Le Jossic-Corcos C; Corcos L
Med Sci (Paris); 2016 Dec; 32(12):1103-1110. PubMed ID: 28044974
[TBL] [Abstract][Full Text] [Related]
30. Targeting Alternative Splicing for Therapeutic Interventions.
Centa JL; Hastings ML
Methods Mol Biol; 2022; 2537():21-36. PubMed ID: 35895256
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.
Lee Y; Rio DC
Annu Rev Biochem; 2015; 84():291-323. PubMed ID: 25784052
[TBL] [Abstract][Full Text] [Related]
32. Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target?
Adamia S; Pilarski PM; Bar-Natan M; Stone RM; Griffin JD
Curr Cancer Drug Targets; 2013 Sep; 13(7):735-48. PubMed ID: 23906050
[TBL] [Abstract][Full Text] [Related]
33. RNA splicing: disease and therapy.
Douglas AG; Wood MJ
Brief Funct Genomics; 2011 May; 10(3):151-64. PubMed ID: 21628314
[TBL] [Abstract][Full Text] [Related]
34. Alternative splicing: a new drug target of the post-genome era.
Hagiwara M
Biochim Biophys Acta; 2005 Dec; 1754(1-2):324-31. PubMed ID: 16260193
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects.
Rigo F; Seth PP; Bennett CF
Adv Exp Med Biol; 2014; 825():303-52. PubMed ID: 25201110
[TBL] [Abstract][Full Text] [Related]
36. In Vitro Modulation of Endogenous Alternative Splicing Using Splice-Switching Antisense Oligonucleotides.
Park JE; Cartegni L
Methods Mol Biol; 2017; 1648():39-52. PubMed ID: 28766288
[TBL] [Abstract][Full Text] [Related]
37. Splice-switching antisense oligonucleotides as therapeutic drugs.
Havens MA; Hastings ML
Nucleic Acids Res; 2016 Aug; 44(14):6549-63. PubMed ID: 27288447
[TBL] [Abstract][Full Text] [Related]
38. [Deregulation of pre-messenger RNA splicing and rare diseases].
de la Grange P
Med Sci (Paris); 2016 Dec; 32(12):1111-1119. PubMed ID: 28044975
[TBL] [Abstract][Full Text] [Related]
39. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing.
Goldstrohm AC; Greenleaf AL; Garcia-Blanco MA
Gene; 2001 Oct; 277(1-2):31-47. PubMed ID: 11602343
[TBL] [Abstract][Full Text] [Related]
40. SR protein kinases: the splice of life.
Stojdl DF; Bell JC
Biochem Cell Biol; 1999; 77(4):293-8. PubMed ID: 10546892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
